BMEA: Biomea Fusion, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 400.53
Enterprise Value ($M) 223.66
Book Value ($M) 169.24
Book Value / Share 4.72
Price / Book 2.37
NCAV ($M) 148.49
NCAV / Share 4.14
Price / NCAV 2.70

Profitability (mra)
Return on Invested Capital (ROIC) -0.65
Return on Assets (ROA) -1.04
Return on Equity (ROE) -1.41

Liquidity (mrq)
Quick Ratio 7.84
Current Ratio 7.84

Balance Sheet (mrq) ($M)
Current Assets 179.18
Assets 199.93
Liabilities 30.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -126.14
Net Income -117.25

Cash Flow Statement (mra) ($M)
Cash From Operations -96.59
Cash from Investing -2.22
Cash from Financing 163.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-10 13G State Street Corp 12.50
02-14 13G/A Baker Bros. Advisors Lp 5.90 0.21
02-12 13G/A Janus Henderson Group Plc 4.80 -37.68
02-12 13G/A Butler Thomas Andrew 10.40 10.13
02-12 13G/A Erdtmann Rainer M 7.80 4.21
02-09 13G/A Fmr Llc 15.00 7.23
02-08 13G Laurion Capital Management LP 7.66
01-29 13G BlackRock Inc. 6.00 148.71
2023-04-03 13D/A Cormorant Global Healthcare Master Fund, LP 10.16 13.19

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-10-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 231,839 1,139,705 20.34
2024-04-18 228,568 603,965 37.84
2024-04-17 110,480 802,858 13.76
2024-04-16 111,018 615,837 18.03
2024-04-15 192,712 712,858 27.03

(click for more detail)

Similar Companies
BEAM – Beam Therapeutics Inc. BIIB – Biogen Inc.
BLUE – bluebird bio, Inc. BMRN – BioMarin Pharmaceutical Inc.
BOLT – Bolt Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io